The SOUL cardiovascular outcomes trial (n=9,650) demonstrated a 14% relative risk reduction in major adverse cardiovascular events with oral semaglutide 14 mg versus placebo over approximately 4 years
4Store as instructed and message your care team for adjustments or questions
Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats
E-Forte-Plus Capsules - Omega 3, Green Tea Extract Citrus Bioflavonoids, Ginkgo Biloba Extract, Ginseng Extract, Grape Seed Extract, Wheat Germ oil, L-Glutathione, Cyanocobalamin and Trace Elements
Monitor your body's response See live drug cycles and medication levels
Patients on either platform should understand that compounded peptides carry additional considerations: compounded semaglutide and tirzepatide are not FDA-approved drugs, meaning they lack branded stability guarantees and rely on 503A pharmacy quality standards